Evidence map›Paper›PMID 38537394›Full record

ArticleSchizophrenia research2024

Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.

Mohammad Ghafouri, Laura Duque, Liliana Patarroyo Rodriguez, Kemuel L Philbrick, Rodolfo Savica, Vanessa K Pazdernik, John D Port, Teresa A Rummans, Balwinder Singh

Abstract readLetter
In one paragraph

Article in Schizophrenia research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Catatonia treatments and risk of recurrence.Journal of affective disorders · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammad GhafouriDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Laura DuqueDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Liliana Patarroyo RodriguezDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Kemuel L PhilbrickDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Rodolfo SavicaDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Vanessa K PazdernikDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
John D PortDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Teresa A RummansDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry, Mayo Clinic, Jacksonville, FL, USA.
Balwinder SinghDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: singh.balwinder@mayo.edu.

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Mayo Clinic Interdisciplinary Women's Health Research ProgramK12HD065987 · NICHD · MAYO CLINIC ROCHESTER · PI KANTARCI, KEJAL · 2010 to 2023
$6.7M
CSRD VA I01 CX002211NCATS NIH HHS UL1 TR002377NCRR NIH HHS M01 RR000585NICHD NIH HHS K12 HD065987
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BrainCatatoniaFluorodeoxyglucose F18Positron-Emission TomographyAdultCase-Control StudiesFemaleHumansMaleMiddle AgedRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals18F-fluorodeoxyglucoseCatatoniaNeuroimagingPositron emission tomographySchizophrenia

Identifiers

PMID38537394
PMCPMC11102829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.